Flavivirus RNA transactions from viral entry to genome replication (Q38964006)

8 September 2017

1 reference

title

Flavivirus RNA transactions from viral entry to genome replication (English)

1 reference

viral entry into host cell

8 September 2017

0 references

1 reference

1 reference

based on heuristic

inferred from abstract

viral genome replication

1 reference

based on heuristic

inferred from abstract

author

Mariano A Garcia-Blanco

series ordinal

1

1 reference

8 September 2017

Subhash G Vasudevan

2

1 reference

PubMed ID

27666184

8 September 2017

Shelton S Bradrick

series ordinal

3

1 reference

PubMed ID

27666184

8 September 2017

Christopher Nicchitta

series ordinal

4

1 reference

8 September 2017

22 September 2016

1 reference

8 September 2017

1 reference

8 September 2017

134

1 reference

8 September 2017

244-249

1 reference

The wMel strain of Wolbachia Reduces Transmission of Zika virus by Aedes aegypti

8 September 2017

2 references

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/SREP28792

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

The global distribution and burden of dengue

1 November 2022

2 references

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE12060

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

1 November 2022

Dengue drug development

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Role of ribosomes in Semliki Forest virus nucleocapsid uncoating

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Dengue Virus Genome Uncoating Requires Ubiquitination

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Biochemical characterization of a recombinant Japanese encephalitis virus RNA-dependent RNA polymerase

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Composition and three-dimensional architecture of the dengue virus replication and assembly sites

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

A CRISPR screen defines a signal peptide processing pathway required by flaviviruses

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Active destruction of defective ribosomes by a ubiquitin ligase involved in DNA repair

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

West Nile virus core protein; tetramer structure and ribbon formation.

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Intracellular localization and determination of a nuclear localization signal of the core protein of dengue virus

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

The stress granule component TIA-1 binds tick-borne encephalitis virus RNA and is recruited to perinuclear sites of viral replication to inhibit viral translation

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Japanese encephalitis virus infection in Vero cells: the involvement of intracellular acidic vesicles in the early phase of viral infection was observed with the treatment of a specific vacuolar type H+-ATPase inhibitor, bafilomycin A1.

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Dengue: an update on treatment options

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Solution structure of dengue virus capsid protein reveals another fold

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Identification of a Conserved RNA-dependent RNA Polymerase (RdRp)-RNA Interface Required for Flaviviral Replication

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Zika virus: History, emergence, biology, and prospects for control

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Dengue Virus Nonstructural Protein 5 (NS5) Assembles into a Dimer with a Unique Methyltransferase and Polymerase Interface

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Field evaluation of the establishment potential of wMelPop Wolbachia in Australia and Vietnam for dengue control

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Nuclear localization of dengue 2 virus core protein detected with monoclonal antibodies

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Efficacy of a tetravalent dengue vaccine in children in Latin America.

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

The C-terminal 18 Amino Acid Region of Dengue Virus NS5 Regulates its Subcellular Localization and Contains a Conserved Arginine Residue Essential for Infectious Virus Production

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Flavivirus RNA methylation

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

RNA Secondary Structure in the Coding Region of Dengue Virus Type 2 Directs Translation Start Codon Selection and Is Required for Viral Replication

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Defining Hsp70 Subnetworks in Dengue Virus Replication Reveals Key Vulnerability in Flavivirus Infection

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

RNA sequences and structures required for the recruitment and activity of the dengue virus polymerase

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

De novo translation initiation on membrane-bound ribosomes as a mechanism for localization of cytosolic protein mRNAs to the endoplasmic reticulum

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Regulated Cleavages at the West Nile Virus NS4A-2K-NS4B Junctions Play a Major Role in Rearranging Cytoplasmic Membranes and Golgi Trafficking of the NS4A Protein

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

G protein-coupled receptor kinase 2 promotes flaviviridae entry and replication

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Poliovirus RNA replication requires genome circularization through a protein-protein bridge

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Formation of membrane-defined compartments by tick-borne encephalitis virus contributes to the early delay in interferon signaling.

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Poly(A)-binding protein binds to the non-polyadenylated 3' untranslated region of dengue virus and modulates translation efficiency

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Molecular basis for specific viral RNA recognition and 2'-O-ribose methylation by the dengue virus nonstructural protein 5 (NS5)

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Nuclear localization of dengue virus capsid protein is required for DAXX interaction and apoptosis

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

pH-dependent solubility shift of rubella virus capsid protein

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Licensed Dengue Vaccine: Public Health Conundrum and Scientific Challenge

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

The development of therapeutic antibodies against dengue virus

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA.

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2016.09.010

10.1016/J.ANTIVIRAL.2016.09.010

1 November 2022

Identifiers

DOI

1 reference

8 September 2017

1 reference

PubMed ID

27666184